Dr. Thomas Schinecker has been appointed as the President of IFPMA.

Appointment

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), based in Geneva, Switzerland, has appointed Dr. Thomas Schinecker, the Chief Executive Officer (CEO) of the Roche Group, as its new President, starting January 1, 2025.


      - He will take over from the current President, Dr. Albert Bourla, who is also the Chairman and CEO of Pfizer, as he completes his term.

      - Before this, Dr. Thomas Schinecker served as the Vice-President of IFPMA for two years.

     

Main Point :-   (i) Rob Davis, CEO of MSD (also known as Merck & Co., Inc.), has been appointed as the new Vice-President of IFPMA.

      (ii) In 2024, Pfizer Inc, based in the United States, is the leading pharmaceutical company in the world, followed by Johnson & Johnson and AbbVie.


          ____________________________